Dr. Ron Shebuski has over 25 years experience in the pharmaceutical industry and served as the Director of Cardiovascular Therapeutics at Pharmacia & Upjohn in Kalamazoo, MI from 1990-1998. He subsequently functioned as VP of R&D for Afmedica, Inc,a Kalamazoo-based biotech start-up that developed a drug-eluting (sirolimus) vascular wrap product to prevent hemodialysis access and peripheral vascular graft failure. Afmedica was acquired by Angiotech Pharmaceuticals (Vancouver, B.C.) in 2005. Previous to directing the cardiovascular group at Pharmacia & Upjohn, where he managed the team responsible for FDA approval in 1995 of the Class III anti-arrhythmic agent, C Read more…

Gayla Ouellette runs Global Preclinical Training and isa consultant specializing in marketing, new business strategies, and corporate events. She has experience in aerospace, cosmetic, technology-development, and biotech industries. She spent 12 years with Charles River as a corporate marketing manager for Preclinical Services and was the marketing director for Sierra Biomedical (SBi) prior to its acquisition by Charles River. Listen to one industry marketers' view on critical points to consider in your marketing as you move into 2010.

John Kapeghian is President of Preclinical Safety Associates a consulting firm specializing in preclinical drug development. John has been on both sides of the business for nearly 25 years with a diverse career spanning both the Pharma and CRO spectrums. Listen to one industry veteran's perspective into the dynamic, evolving preclinical outsourcing landscape.